Review



fluzoparib  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    MedChemExpress fluzoparib
    Fluzoparib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fluzoparib/product/MedChemExpress
    Average 93 stars, based on 2 article reviews
    fluzoparib - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    fluzoparib  (MedChemExpress)
    93
    MedChemExpress fluzoparib
    Fluzoparib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fluzoparib/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    fluzoparib - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    fluzoparib  (Jiangsu Hengrui Medicine)
    90
    Jiangsu Hengrui Medicine fluzoparib
    Fluzoparib, supplied by Jiangsu Hengrui Medicine, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fluzoparib/product/Jiangsu Hengrui Medicine
    Average 90 stars, based on 1 article reviews
    fluzoparib - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    parp inhibitor fluzoparib shr-3162  (Jiangsu Hengrui Medicine)
    90
    Jiangsu Hengrui Medicine parp inhibitor fluzoparib shr-3162
    A list of ICI clinical trials with their protein kinase (PK) inhibitors for SCLC.
    Parp Inhibitor Fluzoparib Shr 3162, supplied by Jiangsu Hengrui Medicine, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/parp inhibitor fluzoparib shr-3162/product/Jiangsu Hengrui Medicine
    Average 90 stars, based on 1 article reviews
    parp inhibitor fluzoparib shr-3162 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    fluzoparib  (Selleck Chemicals)
    91
    Selleck Chemicals fluzoparib
    A list of ICI clinical trials with their protein kinase (PK) inhibitors for SCLC.
    Fluzoparib, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fluzoparib/product/Selleck Chemicals
    Average 91 stars, based on 1 article reviews
    fluzoparib - by Bioz Stars, 2026-03
    91/100 stars
    		  Buy from Supplier
    olaparib  (Selleck Chemicals)
    91
    Selleck Chemicals olaparib
    A list of ICI clinical trials with their protein kinase (PK) inhibitors for SCLC.
    Olaparib, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/olaparib/product/Selleck Chemicals
    Average 91 stars, based on 1 article reviews
    olaparib - by Bioz Stars, 2026-03
    91/100 stars
    		  Buy from Supplier

    Image Search Results


    A list of ICI clinical trials with their protein kinase (PK) inhibitors for SCLC.

    Journal: Cancers

    Article Title: Promises of Protein Kinase Inhibitors in Recalcitrant Small-Cell Lung Cancer: Recent Scenario and Future Possibilities

    doi: 10.3390/cancers16050963

    Figure Lengend Snippet: A list of ICI clinical trials with their protein kinase (PK) inhibitors for SCLC.

    Article Snippet: Another PARP inhibitor, Fluzoparib (also known as SHR-3162, manufactured by Jiangsu Hengrui Medicine Co Ltd., Lianyungang, China), is currently being evaluated in concert with an anti-PD-1 antibody in an open-label, phase II clinical trial (NCT04782089) in patients with ES-SCLC who did not improve after first-line chemotherapy. summarizes the protein kinase (PK) inhibitors being tested in different clinical trials for SCLC.

    Techniques: Clinical Proteomics, Activation Assay, Expressing, In Vivo, Inhibition